Former employeeSonoTheraSouth San Francisco, California, United States
LB 01.2 - Engineering FVIII protein for enhancing expression and secretion profile to achieve normal level of FVIII in plasma utilizing noninvasive transcutaneous ultrasound mediated gene delivery.
Sunday, June 23, 202409:45 – 10:00 ICT
